跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
ROTATEQ SOLUCION ORAL
Approved
STANDARD
ROTATEQ SOLUCION ORAL
Merck Sharp & Dohme B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 18, 2024
Approval ID
8c680abcf3fc132e
Company
Merck Sharp & Dohme B.V.
Type
Standard
Approval Details
Approval Id
8c680abcf3fc132e
Drug Cima Aemps Name
ROTATEQ SOLUCION ORAL
Register Number
06348001IP5
Holder Company Name
Merck Sharp & Dohme B.V.
Marketing Company Name
Difarmed S.L.U.
Holder Company Detail Path
/organization/merck-sharp-and-dohme-bv
Authorization Date
2024-07-18
Dosage Form
SOLUCIÓN ORAL
Dose
Desconocida
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Merck Sharp & Dohme B.V.
Company Detail Path
/organization/merck-sharp-and-dohme-bv
Company Information
Pharmaceutical Company Name
Merck Sharp & Dohme BV
Country Name
Netherlands
Active Ingredients
ROTAVIRUS HUMANO SEROTIPO G2
2,8 U
ROTAVIRUS HUMANO SEROTIPO G1
2,2 U
ROTAVIRUS HUMANO SEROTIPO G3
2,2 U
ROTAVIRUS HUMANO SEROTIPO G4
2 U
ROTAVIRUS HUMANO SEROTIPO P1
2,3 U
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 18, 2024
Approval ID
8c680abcf3fc132e
Type
Standard
Back to CIMA-AEMPS Approvals
ROTATEQ SOLUCION ORAL - CIMA-AEMPS Drug Approval Details